Regeneron Pharmaceuticals shares owned by Stonebridge Capital Management
Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Stonebridge Capital Management
from 13F filings
Historical chart of Stonebridge Capital Management investment in Regeneron Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Regeneron Pharmaceuticals held by Stonebridge Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Regeneron Pharmaceuticals by Stonebridge Capital Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-06-30 | $255k | 485 | 525.77 |
| 2025-03-31 | $308k | 485 | 635.05 |
| 2024-12-31 | $524k | 735 | 712.93 |
| 2024-09-30 | $773k | 735 | 1051.70 |
| 2024-06-30 | $773k | 735 | 1051.70 |
| 2024-03-31 | $707k | 735 | 961.90 |
| 2023-12-31 | $646k | 735 | 878.91 |
| 2023-09-30 | $605k | 735 | 823.13 |
| 2023-06-30 | $535k | 745 | 718.12 |
| 2023-03-31 | $612k | 745 | 821.48 |
| 2022-12-31 | $538k | 745 | 722.15 |
| 2022-09-30 | $634k | 920 | 689.13 |
| 2022-06-30 | $544k | 920 | 591.30 |
| 2022-03-31 | $643k | 920 | 698.91 |
| 2021-12-31 | $581k | 920 | 631.52 |
| 2021-09-30 | $556k | 920 | 604.48 |
| 2021-06-30 | $514k | 920 | 558.21 |
| 2021-03-31 | $435k | 920 | 473.13 |
| 2020-12-31 | $445k | 920 | 483.58 |
| 2020-09-30 | $515k | 920 | 559.70 |
| 2020-06-30 | $560k | 920 | 608.96 |
| 2020-03-31 | $474k | 970 | 488.71 |
| 2019-12-31 | $384k | 1.0k | 376.12 |
| 2019-09-30 | $304k | 1.1k | 277.85 |
| 2019-06-30 | $445k | 1.4k | 313.38 |
| 2019-03-31 | $887k | 2.2k | 410.83 |
| 2018-12-31 | $907k | 2.2k | 404.27 |
| 2018-09-30 | $907k | 2.2k | 404.27 |
| 2018-06-30 | $902k | 2.5k | 361.06 |
| 2018-03-31 | $751k | 2.3k | 321.67 |
| 2017-12-31 | $634k | 1.7k | 366.83 |
More positions owned by Stonebridge Capital Management
View all positions for Stonebridge Capital Management